NCT05486728View on ClinicalTrials.gov

Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

December 7, 2023

Study Completion Date

December 7, 2023

Conditions
Dry Eye Disease
Interventions
DRUG

SHJ002/Vehicle

Topical ophthalmic

Trial Locations (4)

3030

Australian Eye Specialists, Werribee

10330

King Chulalongkorn Memorial Hospital, Bangkok

10400

Ramathibodi Hospital, Mahidol University, Bangkok

813414

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Dreamhawk Vision Biotech, Inc.

INDUSTRY